Osong Public Health and Research Perspectives

Volume 13(1); February 2022

Editorial

As the incidence of Omicron increases, so will the number of deaths: Jong-Koo Lee; Osong Public Health Res Perspect. 2022;13(1):1-3. Published online February 28, 2022; DOI: https://doi.org/10.24171/j.phrp.2022.13.1.01

3,366 View
107 Download
1 Web of Science
1 Crossref

PDF

Citations

Citations to this article as recorded by

Systematic literature review of postponed elections during COVID-19: Campaigns, regulations, and budgets
Anom Wahyu Asmorojati, Suyadi, Zalik Nuryana, Sumaryati, Megawati
Heliyon.2024; 10(4): e25699. CrossRef

Review Articles

Points to consider for COVID-19 vaccine quality control and national lot release in Republic of Korea: focus on a viral vector platform: Jung Hun Ju, Naery Lee, Sun-hee Kim, Seokkee Chang, Misook Yang, Jihyun Shin, Eunjo Lee, Sunhwa Sung, Jung-Hwan Kim, Jin Tae Hong, Ho Jung Oh; Osong Public Health Res Perspect. 2022;13(1):4-14. Published online February 8, 2022; DOI: https://doi.org/10.24171/j.phrp.2021.0311

7,107 View
195 Download

Graphical Abstract Abstract PDF: Due to the global public health crisis caused by the coronavirus disease 2019 (COVID-19) pandemic, the importance of vaccine development has increased. In particular, a rapid supply of vaccines and prompt deployment of vaccination programs are essential to prevent and overcome the spread of COVID-19. As a part of the vaccine regulations, national lot release is regulated by the responsible authorities, and this process involves the assessment of the lot before a vaccine is marketed. A lot can be released for use when both summary protocol (SP) review and quality control testing are complete. Accelerated lot release is required to distribute COVID-19 vaccines in a timely manner. In order to expedite the process by simultaneously undertaking the verification of quality assessment and application for approval, it is necessary to prepare the test methods before marketing authorization. With the prolonged pandemic and controversies regarding the effectiveness of the COVID-19 vaccine against new variants, public interest for the development of a new vaccine are increasing. Domestic developers have raised the need to establish standard guidance on the requirements for developing COVID-19 vaccine. This paper presents considerations for quality control in the manufacturing process, test items, and SP content of viral vector vaccines.

Worldwide prevalence of fungal coinfections among COVID-19 patients: a comprehensive systematic review and meta-analysis: Saber Soltani, Milad Zandi, Samireh Faramarzi, Ramin Shahbahrami, Mohebat Vali, Sara Akhavan Rezayat, Reza Pakzad, Pooneh Malekifar, Iraj Pakzad, Neda Jahandoost, Jalal Moludi; Osong Public Health Res Perspect. 2022;13(1):15-23. Published online February 8, 2022; DOI: https://doi.org/10.24171/j.phrp.2021.0293

8,525 View
131 Download
10 Web of Science

Abstract PDF Supplementary Material: Microbial coinfections can increase the morbidity and mortality rates of viral respiratory diseases. Therefore, this study aimed to determine the pooled prevalence of fungal coinfections in coronavirus disease 2019 (COVID-19) patients. Web of Science, Medline, Scopus, and Embase were searched without language restrictions to identify the related research on COVID-19 patients with fungal coinfections from December 1, 2019, to December 30, 2020. A random-effects model was used for analysis. The sample size included 2,246 patients from 8 studies. The pooled prevalence of fungal coinfections was 12.60%. The frequency of fungal subtype coinfections was 3.71% for Aspergillus, 2.39% for Candida, and 0.39% for other. The World Health Organization’s Regional Office for Europe and Regional Office for Southeast Asia had the highest (23.28%) and lowest (4.53%) estimated prevalence of fungal coinfection, respectively. Our findings showed a high prevalence of fungal coinfections in COVID-19 cases, which is a likely contributor to mortality in COVID-19 patients. Early identification of fungal pathogens in the laboratory for COVID-19 patients can lead to timely treatment and prevention of further damage by this hidden infection.

Yersinia pestis antibiotic resistance: a systematic review: Chen Lei, Suresh Kumar; Osong Public Health Res Perspect. 2022;13(1):24-36. Published online February 18, 2022; DOI: https://doi.org/10.24171/j.phrp.2021.0288

10,426 View
308 Download
14 Web of Science
17 Crossref

Abstract PDF

Yersinia pestis, the cause of plague and a potential biological weapon, has always been a threatening pathogen. Some strains of Y. pestis have varying degrees of antibiotic resistance. Thus, this systematic review was conducted to alert clinicians to this pathogen’s potential antimicrobial resistance. A review of the literature was conducted for experimental reports and systematic reviews on the topics of plague, Y. pestis, and antibiotic resistance. From 1995 to 2021, 7 Y. pestis isolates with 4 antibiotic resistance mechanisms were reported. In Y. pestis 17/95, 16/95, and 2180H, resistance was mediated by transferable plasmids. Each plasmid contained resistance genes encoded within specific transposons. Strain 17/95 presented multiple drug resistance, since plasmid 1202 contained 10 resistance determinants. Strains 16/95 and 2180H showed single antibiotic resistance because both additional plasmids in these strains carried only 1 antimicrobial determinant. Strains 12/87, S19960127, 56/13, and 59/13 exhibited streptomycin resistance due to an rpsl gene mutation, a novel mechanism that was discovered recently. Y. pestis can acquire antibiotic resistance in nature not only via conjugative transfer of antimicrobial-resistant plasmids from other bacteria, but also by gene point mutations. Global surveillance should be strengthened to identify antibiotic-resistant Y. pestis strains by whole-genome sequencing and drug susceptibility testing.

Citations

Citations to this article as recorded by

Seek and you shall find: Yersinia enterocolitica in Ireland’s drinking water
James Powell, Maureen Daly, Nuala H. O’Connell, Colum P. Dunne
Irish Journal of Medical Science (1971 -).2024; 193(4): 1885. CrossRef
A novel sORF gene mutant strain of Yersinia pestis vaccine EV76 offers enhanced safety and improved protection against plague
Xiao Guo, Youquan Xin, Zehui Tong, Shiyang Cao, Yuan Zhang, Gengshan Wu, Hongyan Chen, Tong Wang, Yajun Song, Qingwen Zhang, Ruifu Yang, Zongmin Du, Gregory P. Priebe
PLOS Pathogens.2024; 20(3): e1012129. CrossRef
Interaction between Yersinia pestis Ail Outer Membrane Protein and the C-Terminal Domain of Human Vitronectin
Laurine Vasseur, Florent Barbault, Antonio Monari
The Journal of Physical Chemistry B.2024; 128(16): 3929. CrossRef
Integrated Computational Analysis of Physicochemical Features, Biological Properties, Kinase Target Prediction and Biotransformation Pathways in Drug Discovery
Mohamed Sabri Bensaad, Dhiya Eddine Bensaad, Mohamed Amine Kahoul, Dania S. Waggas, Roua S. Baty, Rokayya Sami, Hamsa Jameel Banjer, Siraj B. Alharthi, Ruqaiah I. Bedaiwi, Zeyad M. Alharbi, Mohammad A. Alanazi, Nouf H. Alsubhi, Ashwaq M. Al-Nazawi, Nada A
International Journal of Pharmacology.2024; 20(5): 748. CrossRef
Emerging Microorganisms and Infectious Diseases: One Health Approach for Health Shared Vision
Maria Vittoria Ristori, Valerio Guarrasi, Paolo Soda, Nicola Petrosillo, Fiorella Gurrieri, Umile Giuseppe Longo, Massimo Ciccozzi, Elisabetta Riva, Silvia Angeletti
Genes.2024; 15(7): 908. CrossRef
Screening of promising molecules against potential drug targets in Yersinia pestis by integrative pan and subtractive genomics, docking and simulation approach
Lei Chen, Lihu Zhang, Yanping Li, Liang Qiao, Suresh Kumar
Archives of Microbiology.2024;[Epub] CrossRef
Plasmonic-Enhanced Colorimetric Lateral Flow Immunoassays Using Bimetallic Silver-Coated Gold Nanostars
Supriya Atta, Yuanhao Zhao, Sebastian Sanchez, Deven Seedial, Jasmine Pramila Devadhasan, Alexander Jarrett Summers, Marcellene A. Gates-Hollingsworth, Kathryn J Pflughoeft, Jian Gu, Douglas C. Montgomery, David P. AuCoin, Frederic Zenhausern, Tuan Vo-Din
ACS Applied Materials & Interfaces.2024; 16(40): 54907. CrossRef
Madagascar’s Plague: One Health Research Aims to Slow Its Spread
Wendee Nicole
Environmental Health Perspectives.2024;[Epub] CrossRef
The Protective Effect of IL-17A in Pneumonic Plague Can Be Compensated by Effective Vaccines and Immunization Strategies in Mice
Emily K. Hendrix, Jian Sha, Paul B. Kilgore, Blake H. Neil, Atul K. Verma, Ashok K. Chopra
Vaccines.2024; 12(12): 1361. CrossRef
Rapid Induction of Protective Immunity against Pneumonic Plague by Yersinia pestis Polymeric F1 and LcrV Antigens
Moshe Aftalion, Avital Tidhar, Yaron Vagima, David Gur, Ayelet Zauberman, Tzvi Holtzman, Arik Makovitzki, Theodor Chitlaru, Emanuelle Mamroud, Yinon Levy
Vaccines.2023; 11(3): 581. CrossRef
Antibiotic resistance in Neisseria gonorrhoeae: broad-spectrum drug target identification using subtractive genomics
Umairah Natasya Mohd Omeershffudin, Suresh Kumar
Genomics & Informatics.2023; 21(1): e5. CrossRef
Polyclonal Antibodies Derived from Transchromosomic Bovines Vaccinated with the Recombinant F1-V Vaccine Increase Bacterial Opsonization In Vitro and Protect Mice from Pneumonic Plague
Sergei S. Biryukov, Hua Wu, Jennifer L. Dankmeyer, Nathaniel O. Rill, Christopher P. Klimko, Kristi A. Egland, Jennifer L. Shoe, Melissa Hunter, David P. Fetterer, Ju Qiu, Michael L. Davies, Christoph L. Bausch, Eddie J. Sullivan, Thomas Luke, Christopher
Antibodies.2023; 12(2): 33. CrossRef
New Bacteriophages with Podoviridal Morphotypes Active against Yersinia pestis: Characterization and Application Potential
Tamar Suladze, Ekaterine Jaiani, Marina Darsavelidze, Maia Elizbarashvili, Olivier Gorge, Ia Kusradze, Tamar Kokashvili, Nino Lashkhi, George Tsertsvadze, Nino Janelidze, Svetlana Chubinidze, Marina Grdzelidze, Shota Tsanava, Eric Valade, Marina Tediashvi
Viruses.2023; 15(7): 1484. CrossRef
Characterization of Mu-Like Yersinia Phages Exhibiting Temperature Dependent Infection
Biao Meng, Zhizhen Qi, Xiang Li, Hong Peng, Shanzheng Bi, Xiao Wei, Yan Li, Qi Zhang, Xiaoqing Xu, Haihong Zhao, Xiaoyan Yang, Changjun Wang, Xiangna Zhao, Olaya Rendueles
Microbiology Spectrum.2023;[Epub] CrossRef
Ancient Yersinia pestis genomes lack the virulence-associated Ypf Φ prophage present in modern pandemic strains
Joanna H. Bonczarowska, Julian Susat, Ben Krause-Kyora, Dorthe Dangvard Pedersen, Jesper Boldsen, Lars Agersnap Larsen, Lone Seeberg, Almut Nebel, Daniel Unterweger
Proceedings of the Royal Society B: Biological Sci.2023;[Epub] CrossRef
A situation analysis of the current plague outbreak in the Demographic Republic of Congo and counteracting strategies – Correspondence
Ranjit Sah, Abdullah Reda, Rachana Mehta, Ranjan K. Mohapatra, Kuldeep Dhama
International Journal of Surgery.2022; 105: 106885. CrossRef
Antimicrobial resistance in Klebsiella pneumoniae: identification of bacterial DNA adenine methyltransferase as a novel drug target from hypothetical proteins using subtractive genomics
Umairah Natasya Mohd Omeershffudin, Suresh Kumar
Genomics & Informatics.2022; 20(4): e47. CrossRef

Original Articles

Associations of pre-existing cardiovascular morbidity with severity and the fatality rate in COVID-19 patients: a systematic review and meta-analysis: Foad Alzoughool, Suhad Abumweis, Lo’ai Alanagreh, Manar Atoum; Osong Public Health Res Perspect. 2022;13(1):37-50. Published online February 18, 2022; DOI: https://doi.org/10.24171/j.phrp.2021.0186

5,522 View
122 Download
5 Web of Science
5 Crossref

Graphical Abstract Abstract PDF Supplementary Material

Objectives
The aim of this study was to evaluate the association of pre-existing cardiovascular comorbidities, including hypertension and coronary heart disease, with coronavirus disease 2019 (COVID-19) severity and mortality. Methods: PubMed, ScienceDirect, and Scopus were searched between January 1, 2020, and July 18, 2020, to identify eligible studies. Random-effect models were used to estimate the pooled event rates of pre-existing cardiovascular disease comorbidities and odds ratio (OR) with 95% confidence intervals (95% CIs) of disease severity and mortality associated with the exposures of interest. Results: A total of 34 studies involving 19,156 patients with COVID-19 infection met the inclusion criteria. The prevalence of pre-existing cardiovascular disease in the included studies was 14.0%. Pre-existing cardiovascular disease in COVID-19 patients was associated with severe outcomes (OR, 4.1; 95% CI, 2.9 to 5.7) and mortality (OR, 6.1; 95% CI, 2.9 to 12.7). Hypertension and coronary heart disease increased the risk of severe outcomes by 2.6 times (OR, 2.6; 95% CI, 1.9 to 3.6) and 2.5 times (OR, 2.5; 95% CI, 1.7 to 3.8), respectively. No significant publication bias was indicated. Conclusion: COVID-19 patients with pre-existing cardiovascular comorbidities have a higher risk of severe outcomes and mortality. Awareness of pre-existing cardiovascular comorbidity is important for the early management of COVID-19.

Citations

Citations to this article as recorded by

Asthma and clinical outcomes of COVID-19 in a community setting
L. Jiao, D. Bujnowski, P. Liu, E. Bakota, L. Liu, Y. Ye, A. Dewangan, C.N. Duong, E. Kviten, S. Zaheer, A. Zangeneh, R. Roy, J. Floyd, J. Monroy, D. Wiltz-Beckham
Public Health.2024; 226: 84. CrossRef
Understanding factors affecting implementation success and sustainability of a comprehensive prevention program for cardiovascular disease in primary health care: a qualitative process evaluation study combining RE-AIM and CFIR
Naomi Aerts, Kathleen Van Royen, Peter Van Bogaert, Lieve Peremans, Hilde Bastiaens
Primary Health Care Research & Development.2023;[Epub] CrossRef
New Scenarios in Heart Transplantation and Persistency of SARS-CoV-2 (Case Report)
Lubov Mitrofanova, Igor Makarov, Andrey Gorshkov, Olga Vorobeva, Maria Simonenko, Anna Starshinova, Dmitry Kudlay, Tatiana Karonova
Life.2023; 13(7): 1551. CrossRef
Prognostic Factors of COVID‐19: An Umbrella Review Endorsed by the International Society for Pharmacoepidemiology
Grammati Sarri, Wei Liu, Luke Zabotka, Andreas Freitag, Ravinder Claire, Grace Wangge, Jamie Elvidge, Dalia Dawoud, Dimitri Bennett, Xuerong Wen, Xiaojuan Li, Christopher T. Rentsch, Md Jamal Uddin, M. Sanni Ali, Mugdha Gokhale, Anouk Déruaz‐Luyet, Daniel
Clinical Pharmacology & Therapeutics.2023; 114(3): 604. CrossRef
Comorbidities in congenital heart disease: different patterns in childhood and adulthood
Zhibao Ding, Jingai Zhu, Ye Ding, Chun Zhu
BMC Cardiovascular Disorders.2023;[Epub] CrossRef

Generalized anxiety and sleep quality among health care professionals during the COVID-19 pandemic: a cross-sectional study from a tertiary healthcare institution in Eastern India: Bijaya Nanda Naik, Sanjay Pandey, Rajath Rao, Manisha Verma, Prashant Kumar Singh; Osong Public Health Res Perspect. 2022;13(1):51-61. Published online February 8, 2022; DOI: https://doi.org/10.24171/j.phrp.2021.0316

6,425 View
83 Download
4 Web of Science
3 Crossref

Abstract PDF

Objectives
With the emergence of the coronavirus disease 2019 (COVID-19) pandemic, healthcare professionals (HCPs) have experienced high levels of stress and anxiety because of the high risk of infection for themselves and their families. This has led to acute sleep problems for HCP. This study was designed to assess the anxiety and sleep quality of HCPs during the COVID-19 pandemic. Methods: This cross-sectional study analyzed 370 HCPs employed at All India Institute of Medical Sciences Patna over 3 months, using the standard Generalized Anxiety Disorder 7-item scale (GAD-7) for suspected GAD and the Pittsburgh Sleep Quality Index for sleep quality. Results were tabulated and multivariable binomial logistic regression analysis was done to determine the predictors of poor sleep. Significance was attributed to p<0.05. Results: Of the 370 HCPs screened, 52 (14.1%; 95% confidence interval [CI], 10.8%–18.1%) were found to have GAD and 195 (52.7%; 95% CI, 47.5%–57.9%) were found to be poor sleepers. The presence of any addictive habit (adjusted odds ratio [AOR], 1.833; 95% CI, 1.12–2.8), unprotected contact with COVID-19 cases (AOR, 1.902; 95% CI, 1.1–3.3), and the presence of GAD (AOR, 5.57; 95% CI, 2.5–12.4) were found to be predictors of poor sleep quality among HCPs. Conclusion: A significant proportion of HCPs were found to have suspected GAD and were poor sleepers. This highlights the need for measures to confront this problem.

Citations

Citations to this article as recorded by

Stigmatization experiences of healthcare workers in the context of the COVID-19 pandemic: a scoping review
Reza Negarandeh, Mehraban Shahmari, Leily Zare
BMC Health Services Research.2024;[Epub] CrossRef
COVID-19 Pandemic and Challenges Faced by Healthcare Professionals in India
Shibajee Debbarma
Cureus.2023;[Epub] CrossRef
Comparison of General Anxiety among Healthcare Professionals before and after COVID-19 Vaccination
Zohair Badami, Hareem Mustafa, Afsheen Maqsood, Soha Aijaz, Sara Altamash, Abhishek Lal, Sara Saeed, Naseer Ahmed, Rahima Yousofi, Artak Heboyan, Mohmed Karobari
Vaccines.2022; 10(12): 2076. CrossRef

Predictors of health-related quality of life in Koreans with cardiovascular disease: Jung-Hye Lim; Osong Public Health Res Perspect. 2022;13(1):62-70. Published online February 22, 2022; DOI: https://doi.org/10.24171/j.phrp.2021.0286

4,852 View
101 Download
1 Web of Science
1 Crossref

Graphical Abstract Abstract PDF

Objectives
This study aimed to identify the predictors of health-related quality of life (HRQoL) in Korean adults with cardiovascular disease (CVD). Methods: This was a cross-sectional study with a stratified multistage probability sampling design. Data from the 2016 to 2019 Korea National Health and Nutrition Examination Survey (n=32,379) were used. Among the participants aged 19 years or older (n=25,995), 1,081 patients with CVD were extracted after excluding those with missing data and those who had cancer. The participants’ HRQoL was measured using the three-level EuroQoL Group’s five-dimension questionnaire (EQ-5D) scale. Data were analyzed using the t-test, one-way analysis of variance, and general linear regression for complex samples. Results: The most potent predictors of HRQoL in Korean adults with CVD were limited activity (β =−0.103, p <0.001), poor perceived health (β =−0.089, p <0.001), depression (β =−0.065, p<0.01), low household income (β=−0.033, p<0.05), unemployment (β=−0.023, p<0.05), and older age (β=−0.002, p<0.01), which explained 37.2% of the variance. Conclusion: Comprehensive interventions that address both physical and mental factors and social systems that provide financial help need to be implemented to improve the HRQoL of Korean adults with CVD.

Citations

Citations to this article as recorded by

Factors associated with health-related quality of life in patients with coronary heart disease
Febio Gutama, Melisa Intan Barliana, Irma Melyani Puspitasari
Pharmacia.2022; 69(3): 771. CrossRef

Neck circumference and incidence of cerebrovascular disease over 12 years among Korean adults: Jae-Seon Han, Yun-Hee Kim; Osong Public Health Res Perspect. 2022;13(1):71-79. Published online February 8, 2022; DOI: https://doi.org/10.24171/j.phrp.2021.0277

4,225 View
66 Download
4 Web of Science
4 Crossref

Abstract PDF

Objectives
Neck circumference is associated with a distinctive fat storage process that confers additional metabolic risk. Hence, this study aimed to investigate the correlation between baseline neck circumference and the incidence of cerebrovascular disease using a prospective community-based sample of Korean adults over 12 years of follow-up, after controlling for selected covariates. Methods: Participants with non-cerebrovascular disease were divided into 4 groups (Q1–Q4) based on their baseline neck circumference. Cox proportional hazards analysis was used to calculate hazard ratios and 95% confidence intervals (CIs) to evaluate the relationship between neck circumference and cerebrovascular disease incidence over a 12-year period. Results: Among this study’s 3,662 participants, 128 (3.50%) developed cerebrovascular disease. The incidence of cerebrovascular disease increased from 2.2% in Q1 to 4.3% in Q2, 2.5% in Q3, and 5.0% in Q4. When compared to Q1, the relative risks of cerebrovascular disease development were 0.57 (95% CI, 0.25–1.31), 0.86 (95% CI, 0.38–1.96), and 0.79 (95% CI, 0.30–2.07) in man and 1.86 (95% CI, 0.66–5.20), 3.50 (95% CI, 1.25–9.86), and 4.71 (95% CI, 1.50–14.77) in woman in Q2, Q3, and Q4, respectively, after adjusting for most risk factors related to cerebrovascular disease. Conclusion: The relationship between neck circumference and cerebrovascular disease was stronger in woman than in man, indicating potential differences between the sexes. These results are meaningful for evaluating and surveilling neck circumference as a promising tool for identifying subgroups of vulnerable and at-risk populations.

Citations

Citations to this article as recorded by

Neck circumference as a predictor of all-cause mortality in middle-aged and older adults in rural Ecuador
Oscar H Del Brutto, Denisse A Rumbea, Maitri Patel, Robertino M Mera
International Health.2024;[Epub] CrossRef
Adult obesity diagnostic tool: A narrative review
Xiaolong Liu, Mengxiao He, Yi Li
Medicine.2024; 103(17): e37946. CrossRef
The association between physical activity and neck circumference with cardiovascular disease risk in older wheelchair users
Jeonghyeon Kim, Inhwan Lee, Hyunsik Kang
Journal of Rehabilitation Medicine.2024; 56: jrm35279. CrossRef
The association of Carbohydrate Quality Index with cardiovascular disease risk factors among women with overweight and obesity: A cross-sectional study
Darya Khosravinia, Farideh Shiraseb, Atieh Mirzababaei, Elnaz Daneshzad, Shahin Jamili, Cain C. T. Clark, Khadijeh Mirzaei
Frontiers in Nutrition.2022;[Epub] CrossRef

Corrigendum

Correction to “Prevalence and Associated Factors of Hypertension Subtypes Among the Adult Population in Nepal: Evidence from Demographic and Health Survey Data” [Osong Public Health Res Perspect 2019;10(6):327–36]: Rajat Das Gupta, Animesh Talukder, Shams Shabab Haider, Mohammad Rifat Haider; Osong Public Health Res Perspect. 2022;13(1):80-80. Published online February 28, 2022; DOI: https://doi.org/10.24171/j.phrp.2019.10.6.02.e1; Corrects: Osong Public Health Res Perspect 2019;10(6):327

2,943 View
38 Download

PDF

First
Prev
Page of 1
Next
Last

Previous issues